Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 12, 2022
Patent Application Number
16814661
Date Filed
March 10, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
